| Title | S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery |
|---|---|
| Disease/Condition | Pancreatic Cancer |
| Eligibility Criteria | Ages Eligible for Study: 18 Years to 75 Years (Adult, Senior) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | Lakshmi Rajdev, MD |
| Contact Name | Karen Fehn |
| Phone | (718) 405-8446 |
| Contact Email | CPDMUtrialinfo@montefiore.org |
| IRB/Protocol Number | IRB# 2016-6464 |
| Status | Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |